Savant Capital LLC trimmed its holdings in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 78.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,861 shares of the health services provider’s stock after selling 10,340 shares during the period. Savant Capital LLC’s holdings in Maximus were worth $247,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently bought and sold shares of MMS. Farther Finance Advisors LLC grew its stake in Maximus by 69.0% in the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after purchasing an additional 116 shares in the last quarter. Advisory Services Network LLC purchased a new position in Maximus in the third quarter valued at about $32,000. Canada Pension Plan Investment Board purchased a new position in Maximus in the second quarter valued at about $35,000. Richardson Financial Services Inc. grew its stake in Maximus by 29.6% in the fourth quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock valued at $39,000 after purchasing an additional 103 shares in the last quarter. Finally, Danske Bank A S purchased a new position in Maximus in the third quarter valued at about $55,000. 97.21% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
MMS has been the topic of a number of recent research reports. Wall Street Zen upgraded Maximus from a “hold” rating to a “buy” rating in a research note on Saturday. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Weiss Ratings downgraded Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Maximus presently has an average rating of “Hold”.
Insider Transactions at Maximus
In other Maximus news, Director Jan Madsen sold 742 shares of Maximus stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the completion of the transaction, the director owned 20,795 shares in the company, valued at approximately $1,502,438.75. The trade was a 3.45% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.80% of the company’s stock.
Maximus Price Performance
Shares of NYSE:MMS opened at $60.49 on Monday. The business has a 50 day moving average price of $63.79 and a 200 day moving average price of $76.60. Maximus, Inc. has a twelve month low of $56.92 and a twelve month high of $100.00. The company has a market cap of $3.18 billion, a price-to-earnings ratio of 9.06 and a beta of 0.58. The company has a quick ratio of 2.21, a current ratio of 2.21 and a debt-to-equity ratio of 0.87.
Maximus (NYSE:MMS – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The health services provider reported $2.07 EPS for the quarter, beating the consensus estimate of $1.98 by $0.09. The firm had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The company’s revenue for the quarter was down 4.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.01 EPS. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Research analysts predict that Maximus, Inc. will post 8.43 earnings per share for the current year.
Maximus Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were given a $0.33 dividend. The ex-dividend date was Friday, May 15th. This represents a $1.32 annualized dividend and a yield of 2.2%. Maximus’s payout ratio is presently 19.76%.
Maximus Company Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Featured Articles
- Five stocks we like better than Maximus
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
